Strategies for developing a Helicobacter pylori vaccine
- 1 November 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Gastroenterology
- Vol. 15 (6), 557-61
- https://doi.org/10.1097/00001574-199911000-00017
Abstract
Novel strategies are needed to control infection with Helicobacter pylori. Prophylactic and therapeutic immunization against this gastric pathogen is possible in animal models, and initial human studies in H. pylori–infected subjects showed that immunization with H. pylori urease is both safe and immunogenic. In rodents, gastric protection against Helicobacter species infection does not depend on the humoral immune response, and a prominent role of the major histocompatibility complex II–restricted CD4+ T-cell response is recognized; however, much remains to be learned about the mechanisms of effective bactericidal response. A clear understanding of the basic mechanisms of gastric immune protection in humans is of the utmost importance for the development of an effective human vaccine. More potent vaccines are likely to be required to induce protection in humans. The availability of two complete genome sequences of H. pylori represents a unique opportunity to identify novel vaccine antigens. Multivalent vaccines delivered by recombinant attenuated bacteria or administered with nontoxic adjuvants need to be evaluated in relevant models.Keywords
This publication has 40 references indexed in Scilit:
- Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeysVaccine, 1999
- Antibody-Independent Protective Mucosal Immunity to Gastric Helicobacter Infection in MiceCellular Immunology, 1999
- Differential α4β7-integrin and L-selectin homing receptor expression during natural and vaccine-induced immune responses to Helicobacter infection in miceGastroenterology, 1998
- Cost-effectivieness of vaccine development for H. Pylori using the institute of medicine (IOM) modelGastroenterology, 1998
- Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infectionVaccine, 1997
- Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infectionThe Lancet, 1996
- Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis.Gut, 1995
- Gastric T lymphocyte responses to Helicobacter pylori in patients with H pylori colonisation.Gut, 1994
- Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunizationVaccine, 1993
- Immunisation against gastric infection with Helicobacter species: First step in the prophylaxis of gastric cancer?Zentralblatt für Bakteriologie, 1993